NAA10

gene product
ARD1, ARD1A, DXS707, TE2
N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
157 antibodies from 26 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
GeneTex
3 antibodies
Novus Biologicals
7 antibodies
Invitrogen Antibodies
3 antibodies
antibodies-online
57 antibodies
NovoPro Bioscience Inc.
8 antibodies
LifeSpan BioSciences, Inc.
37 antibodies
Proteintech Group
1 antibody
Atlas Antibodies
1 antibody
Biorbyt
5 antibodies
Abnova Corporation
5 antibodies
Abgent
1 antibody
Bioworld Technology, Inc
1 antibody
St John's Laboratory
1 antibody
Cell Signaling Technology, Inc
2 antibodies
Aviva Systems Biology
1 antibody
NSJ Bioreagents
1 antibody
OriGene
1 antibody
MyBioSource
3 antibodies
Creative Biolabs
5 antibodies
ProSci
3 antibodies
Creative Diagnostics
3 antibodies
Affinity Biosciences
1 antibody
Boster Biological Technology
1 antibody
Sigma-Aldrich
3 antibodies
United States Biological
1 antibody
Acris Antibodies GmbH
2 antibodies